Page 4 - Evolan Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evolan pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evolan Pharma Today - Breaking & Trending Today

"The occupational burden associated with ADHD is substantial"


 E-Mail
The occupational burden associated with ADHD is substantial , with individuals with ADHD earning average annual incomes 17 percent lower than controls, finds study tracking 1.2 million Swedish high school graduates.
###
Article Title: Attention-deficit/hyperactivity disorder and occupational outcomes: The role of educational attainment, comorbid developmental disorders, and intellectual disability
Funding: This study received funding from the Swedish Research Council (Vetenskapsrådet, award: 2018-02599), and through a grant from Shire International GmbH, a member of Takeda group of companies, Zug, Switzerland. Dr. Bulik acknowledges funding from the Swedish Research Council (award: 538-2013-8864). Although the sponsor (Shire) was involved in the design, collection, analysis, interpretation of the data, and writing of the report, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication in ....

Evolan Pharma , Swedish Research Council Vetenskapsr , Swedish Research Council , Shire International Gmb , Shire International Gmbh , Scientific Advisory Board , Social Behavioral Science , ஸ்விட்ச் ஆராய்ச்சி சபை , ஶைர் சர்வதேச க்ம்ப் , ஶைர் சர்வதேச கஂப் , சமூக நடத்தை அறிவியல் ,